Literature DB >> 35351268

Recent clinical research on the application of liquid biopsy in neuroblastoma.

Si-Yang Liu1, Fei-Qiu Wen1.   

Abstract

Neuroblastoma (NB) is the most common extracranial solid tumor in children and has the features of high recurrence rate and low survival rate, and therefore, early diagnosis, treatment response evaluation, and recurrence monitoring are of great significance for NB patients. Liquid biopsy refers to the detection of cells and nucleic acids in fluid specimens, mainly blood. It is noninvasive and can overcome tumor heterogeneity, thus making it possible to achieve the early diagnosis and dynamic detection of NB. This review introduces the latest advances in clinical research on the application of liquid biopsy in NB.

Entities:  

Keywords:  Child; Circulating tumor DNA; Circulating tumor cell; Exosome; Liquid biopsy; Neuroblastoma

Mesh：

Year:  2022        PMID： 35351268      PMCID： PMC8974650          DOI： 10.7499/j.issn.1008-8830.2112120

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN： 1008-8830


  32 in total

1.  Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.

Authors:  Fjoralba Zeka; Anneleen Decock; Alan Van Goethem; Katrien Vanderheyden; Fleur Demuynck; Tim Lammens; Hetty H Helsmoortel; Joëlle Vermeulen; Rosa Noguera; Ana P Berbegall; Valérie Combaret; Gudrun Schleiermacher; Geneviève Laureys; Alexander Schramm; Johannes H Schulte; Sven Rahmann; Julie Bienertová-Vašků; Pavel Mazánek; Marta Jeison; Shifra Ash; Michael D Hogarty; Mirthala Moreno-Smith; Eveline Barbieri; Jason Shohet; Frank Berthold; Tom Van Maerken; Frank Speleman; Matthias Fischer; Katleen De Preter; Pieter Mestdagh; Jo Vandesompele
Journal:  JCI Insight       Date:  2018-12-06

2.  Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.

Authors:  Julie R Park; Susan G Kreissman; Wendy B London; Arlene Naranjo; Susan Lerner Cohn; Michael D Hogarty; Sheena C Tenney; Daphne Haas-Kogan; Peter John Shaw; Jacqueline M Kraveka; Stephen S Roberts; James Duncan Geiger; John J Doski; Stephan D Voss; John M Maris; Stephan A Grupp; Lisa Diller
Journal:  JAMA       Date:  2019-08-27       Impact factor: 56.272

Review 3.  Integrating liquid biopsies into the management of cancer.

Authors:  Giulia Siravegna; Silvia Marsoni; Salvatore Siena; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2017-03-02       Impact factor: 66.675

4.  Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction.

Authors:  Constantin Peitz; Annika Sprüssel; Rasmus B Linke; Kathy Astrahantseff; Maddalena Grimaldi; Karin Schmelz; Joern Toedling; Johannes H Schulte; Matthias Fischer; Clemens Messerschmidt; Dieter Beule; Ulrich Keilholz; Angelika Eggert; Hedwig E Deubzer; Marco Lodrini
Journal:  J Mol Diagn       Date:  2020-08-26       Impact factor: 5.568

5.  Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.

Authors:  Mathieu Chicard; Sandrine Boyault; Leo Colmet Daage; Wilfrid Richer; David Gentien; Gaelle Pierron; Eve Lapouble; Angela Bellini; Nathalie Clement; Isabelle Iacono; Stéphanie Bréjon; Marjorie Carrere; Cécile Reyes; Toby Hocking; Virginie Bernard; Michel Peuchmaur; Nadège Corradini; Cécile Faure-Conter; Carole Coze; Dominique Plantaz; Anne Sophie Defachelles; Estelle Thebaud; Marion Gambart; Frédéric Millot; Dominique Valteau-Couanet; Jean Michon; Alain Puisieux; Olivier Delattre; Valérie Combaret; Gudrun Schleiermacher
Journal:  Clin Cancer Res       Date:  2016-07-20       Impact factor: 12.531

6.  Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.

Authors:  Mathieu Chicard; Leo Colmet-Daage; Nathalie Clement; Adrien Danzon; Mylène Bohec; Virginie Bernard; Sylvain Baulande; Angela Bellini; Paul Deveau; Gaëlle Pierron; Eve Lapouble; Isabelle Janoueix-Lerosey; Michel Peuchmaur; Nadège Corradini; Anne Sophie Defachelles; Dominique Valteau-Couanet; Jean Michon; Valérie Combaret; Olivier Delattre; Gudrun Schleiermacher
Journal:  Clin Cancer Res       Date:  2017-11-30       Impact factor: 12.531

7.  Cell surface vimentin-positive circulating tumor cell-based relapse prediction in a long-term longitudinal study of postremission neuroblastoma patients.

Authors:  Izhar S Batth; Long Dao; Arun Satelli; Abhisek Mitra; Sofia Yi; Hyangsoon Noh; Heming Li; Zachary Brownlee; Shouhao Zhou; Jeffrey Bond; Jing Wang; Jonathan Gill; Giselle S Sholler; Shulin Li
Journal:  Int J Cancer       Date:  2020-06-23       Impact factor: 7.316

8.  Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells.

Authors:  Chiara Degli Esposti; Barbara Iadarola; Simone Maestri; Cristina Beltrami; Denise Lavezzari; Martina Morini; Patrizia De Marco; Giovanni Erminio; Alberto Garaventa; Federico Zara; Massimo Delledonne; Marzia Ognibene; Annalisa Pezzolo
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

9.  Novel Circulating Hypermethylated RASSF1A ddPCR for Liquid Biopsies in Patients With Pediatric Solid Tumors.

Authors:  Lieke M J van Zogchel; Nathalie S M Lak; Onno J H M Verhagen; Ahmed Tissoudali; Mohammed Gussmalla Nuru; Nina U Gelineau; Lily Zappeij-Kannengieter; Ahmad Javadi; Eline A M Zijtregtop; Johannes H M Merks; Marry van den Heuvel-Eibrink; Antoinette Y N Schouten-van Meeteren; Janine Stutterheim; C Ellen van der Schoot; Godelieve A M Tytgat
Journal:  JCO Precis Oncol       Date:  2021-11-17

10.  Plasma cell-free DNA quantification is highly correlated to tumor burden in children with neuroblastoma.

Authors:  Xisi Wang; Lijun Wang; Yan Su; Zhixia Yue; Tianyu Xing; Wen Zhao; Qian Zhao; Chao Duan; Cheng Huang; Dawei Zhang; Mei Jin; Xianfeng Cheng; Shenglan Chen; Yi Liu; Xiaoli Ma
Journal:  Cancer Med       Date:  2018-06-14       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.